KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA, CERGEN study team. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.

2012
https://researcherprofiles.org/profile/1167010
23155138

Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA, CERGEN study team